oa Cardiovascular risk assessment for patients with serious mental illnesses: An internal review

References

1. Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry. 2007; 64:(2):242–9.
   [Google Scholar]
2. De Hert M, Detraux J, Vancampfort D. The intriguing relationship between coronary heart disease and mental disorders. Dial Clin Neurosci. 2018; 20:(1):31–40.
   [Google Scholar]
3. Drici MD, Priori S. Cardiovascular risks of atypical antipsychotic drug treatment. J Pharmacoepidemiol. 2007; 16:(8):882–90.
   [Google Scholar]
4. Hammoudeh S, Ghuloum S, Mahfoud Z, Yehya A, Abdulhakam A, Al-Mujalli A, et al. The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study. BMC Psychiatry. 2018; 18:(1):81.
   [Google Scholar]
5. American College of Cardiology. ASCVD risk estimator plus [Internet]; 2014. Available from: https://www.acc.org/Tools-and-Practice-Support/Mobile-Resources/Features/2013-Prevention-Guidelines-ASCVD-Risk-Estimator. Accessed 28 June 2021.
6. Sartorious N. Comorbidity of mental and physical diseases: a main challenge for medicine of the 21st century. Shanghai Arch Psychiatry. 2013; 25:(2):68–9.
   [Google Scholar]
7. Zolezzi M, Abdulrhim S, Isleem N, Zahrah F, Eltorki Y. Medical comorbidities in patients with serious mental illness: a retrospective study of mental health patients attending an outpatient clinic in Qatar. Neuropsychiatr Dis Treat. 2017;13:2411–8.
   [Google Scholar]
8. Qureshi NA, Van Der Molen HT, Schmidt HG, Al Habeeb TA, Magzoub ME. Criteria for a good referral system for psychiatric patients: the view from Saudi Arabia. East Mediterr Health J. 2009; 15:(6):1580–95.
   [Google Scholar]